Table 6.
No. Patients | 0 | 1 | 2 | 3 | 4 | P-value | |
---|---|---|---|---|---|---|---|
aCombined PD-1 Level, n (%) | |||||||
Stage of cancer | |||||||
I-II | 9 | 0 (0.0) | 0 (0.0) | 6 (66.7) | 1 (11.1) | 2 (22.2) | 0.028 |
III-IV | 46 | 7 (15.2) | 8 (17.4) | 23 (50.0) | 7 (15.2) | 1 (2.2) | |
Tumor grade | |||||||
1–2 | 13 | 1 (7.7) | 4 (30.8) | 7 (53.8) | 0 (0.0) | 1 (7.7) | 0.54 |
3 | 41 | 6 (14.6) | 4 (9.8) | 21 (51.2) | 8 (19.5) | 2 (4.9) |
aCombined PD-1 was derived by adding the observed pathology scores for tumor PD-1 (T-PD-1) and S-PD-1 in each patient tumor section. Significant P-value in table is indicated in italics